The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global digital pathology market reached a value of US$ 764.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,409.1 Million by 2027, exhibiting a CAGR of 10.85% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Digital pathology (DP) is a dynamic and image-based system that facilitates acquisition, management and interpretation of information related to human and animal pathology. It processes digital data through scanners, information management systems, storage devices, visualizing software and web and cloud-based communication systems. The DP systems analyze high-resolution samples and store digital slides on a server or the cloud. This enables the pathologists to cross-examine slides in the absence of physical evidence. They also aid in minimizing costs and improving the accuracy of the test results. Consequently, they find extensive application in teleconsultation, disease diagnosis and drug discovery across the educational, medical and pharmaceutical industries.
The rising trend of digitization, along with the increasing adoption of telepathology across the globe, is one of the key factors driving the growth of the market. Telepathology aids in faster and efficient disease diagnosis and ease in consultation, owing to which it is rapidly being incorporated across various healthcare and diagnostic centers. Furthermore, the rising prevalence of chronic medical ailments, such as cancer, is also providing a boost to the market growth. Additionally, various technological advancements, including the integration of Laboratory Information Systems (LIS) and the introduction of digital imaging, robotic light microscopy and multiple fiber-optic communications, are impacting the market positively. Other factors, including rising geriatric population and extensive research and development (R&D) activities in the pharmaceutical and bioscience sectors, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global digital pathology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, type, delivery model, end-user and application.
Breakup by Product:
Breakup by Type:
Breakup by Delivery Model:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being DHISTECH, Apollo Enterprise Imaging, Corista, Hamamatsu Photonics, Huron Digital Pathology, Indica Labs, Koninklijke Philips, Leica Biosystems, Objective Pathology Services, Ventana Medical Systems, Visiopharm and XIFIN, etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Type, Delivery Model, End-User, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Colombia, Argentina, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates|
|Companies Covered||DHISTECH, Apollo Enterprise Imaging, Corista, Hamamatsu Photonics, Huron Digital Pathology, Indica Labs, Koninklijke Philips, Leica Biosystems, Objective Pathology Services, Ventana Medical Systems, Visiopharm and XIFIN|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at